Cyclodextrin Based Nanoparticles for Drug Delivery and Theranostics

Colloidal nanoparticulate technology has been described in the literature as a versatile drug delivery system. But it possesses some inherent lacunae in their formulation. Cyclodextrins (CDs) have been extensively reported for the solubility enhancement of poorly water-soluble drugs. The CDs can cau...

Full description

Saved in:
Bibliographic Details
Main Authors: Dipak Dilip Gadade (Author), Sanjay Sudhakar Pekamwar (Author)
Format: Book
Published: Tabriz University of Medical Sciences, 2020-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_6d5d1b038d554a918d57ab1a57a8b347
042 |a dc 
100 1 0 |a Dipak Dilip Gadade  |e author 
700 1 0 |a Sanjay Sudhakar Pekamwar  |e author 
245 0 0 |a Cyclodextrin Based Nanoparticles for Drug Delivery and Theranostics 
260 |b Tabriz University of Medical Sciences,   |c 2020-02-01T00:00:00Z. 
500 |a 2228-5881 
500 |a 2251-7308 
500 |a 10.34172/apb.2020.022 
520 |a Colloidal nanoparticulate technology has been described in the literature as a versatile drug delivery system. But it possesses some inherent lacunae in their formulation. Cyclodextrins (CDs) have been extensively reported for the solubility enhancement of poorly water-soluble drugs. The CDs can cause intervention in aspects related to nanoparticles (NPs) that include improving drug loading in nano-system, improving stability, site-specific/targeted drug delivery, improving solubility profile and absorption of the drug in nanosystem with consequent improvement in bioavailability, with the possibility of controlled release, safety and efficacy. They find application in for simultaneous diagnosis and therapeutics for better treatment procedures. The current communication is focused on the application of CDs to overcome troubles in nanoparticulate formulation and enhancement of their performance. It also envisages the theranostic aspects of CDs. 
546 |a EN 
690 |a cyclodextrin 
690 |a nanoparticle 
690 |a solubility 
690 |a theranotics 
690 |a stability 
690 |a controlled release 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Advanced Pharmaceutical Bulletin, Vol 10, Iss 2, Pp 166-183 (2020) 
787 0 |n https://apb.tbzmed.ac.ir/PDF/apb-27565 
787 0 |n https://doaj.org/toc/2228-5881 
787 0 |n https://doaj.org/toc/2251-7308 
856 4 1 |u https://doaj.org/article/6d5d1b038d554a918d57ab1a57a8b347  |z Connect to this object online.